You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
神州細胞(688520.SH):預計一季度淨利潤6000萬元至8000萬元 同比扭虧
格隆匯 04-17 18:10

格隆匯4月17日丨神州細胞(688520.SH)公佈,經公司財務部門初步測算,預計公司2024年第一季度實現營業收入60,000萬元至62,000萬元,與上年同期相比,將增長27,000萬元至29,000萬元,同比增長82.12%至88.21%。預計公司2024年第一季度實現歸屬於母公司所有者的淨利潤6,000萬元至8,000萬元,由虧轉盈。預計公司2024年第一季度實現歸屬於母公司所有者的扣除非經常性損益後的淨利潤14,500萬元至16,500萬元,由虧轉盈。

公司2024年第一季度預計實現營業收入6億元到6.2億元,以及實現由虧轉盈,主要系因公司產品銷售收入持續穩定增長,以及通過控制運營成本、提高研發效率等方式降本增效所致。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account